265 related articles for article (PubMed ID: 38007992)
41. A network pharmacology approach to explore active compounds and pharmacological mechanisms of a patented Chinese herbal medicine in the treatment of endometriosis.
Wu Y; Zhu Y; Xie N; Wang H; Wang F; Zhou J; Qu F
PLoS One; 2022; 17(2):e0263614. PubMed ID: 35130311
[TBL] [Abstract][Full Text] [Related]
42. Traditional Chinese medicine for mild cognitive impairment: A protocol for systematic review and network meta-analysis.
Wang H; Yu H; Song K; Xiong F; Zhang H
Medicine (Baltimore); 2020 Sep; 99(37):e22187. PubMed ID: 32925791
[TBL] [Abstract][Full Text] [Related]
43. [Exploiture and application of an internet-based Computation Platform for Integrative Pharmacology of Traditional Chinese Medicine].
Xu HY; Liu ZM; Fu Y; Zhang YQ; Yu JJ; Guo FF; Tang SH; Lv CY; Su J; Cui RY; Yang HJ
Zhongguo Zhong Yao Za Zhi; 2017 Sep; 42(18):3633-3638. PubMed ID: 29218953
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of outcomes of randomized controlled trial on compound Chinese herbal medicine formulas in treatment of vascular cognitive impairment caused by cerebral small vessel].
Zhang XY; Liao X; Liu XM; Xia RY; Liang X; Xu ZM; Li X; Li NN; Chen ZG
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5804-5818. PubMed ID: 33496122
[TBL] [Abstract][Full Text] [Related]
45. [Traditional Chinese medicine network pharmacology: development in new era under guidance of network pharmacology evaluation method guidance].
Wang ZY; Wang X; Zhang DY; Hu YJ; Li S
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):7-17. PubMed ID: 35178906
[TBL] [Abstract][Full Text] [Related]
46. [Structural components of Chinese medicine and pharmacology network: systematical overall regulation on pathological network].
Chen J; Gu JF; Wang CF; Yuan JR; Zhao BJ; Zhang L; Cheng XD; Feng L; Jia XB
Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):758-64. PubMed ID: 26137704
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis.
Wang K; Yin J; Chen J; Ma J; Si H; Xia D
Phytomedicine; 2024 Jun; 128():155258. PubMed ID: 38522318
[TBL] [Abstract][Full Text] [Related]
48. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
[TBL] [Abstract][Full Text] [Related]
49. Neuropsychological assessment and cerebral vascular disease: the new standards.
Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
[TBL] [Abstract][Full Text] [Related]
50. Network Pharmacology Analysis to Explore the Pharmacological Mechanism of Effective Chinese Medicines in Treating Metastatic Colorectal Cancer using Meta-Analysis Approach.
Zhu Y; Yu J; Zhang K; Feng Y; Guo K; Sun L; Ruan S
Am J Chin Med; 2021; 49(8):1839-1870. PubMed ID: 34781857
[TBL] [Abstract][Full Text] [Related]
51. [Research initiative of new thought on "main effect" of TCM formulae--new thinking on mechanism of compound action and compatibility mechanism of Chinese herbal compound formulae].
Weng XG; Li YJ; Chen Y; Yang Q; Wang YJ; Li Q; Cai WY; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(18):3782-3786. PubMed ID: 30384546
[TBL] [Abstract][Full Text] [Related]
52. Synthetic lethality theory approaches to effective substance discovery and functional mechanisms elucidation of anti-cancer phytomedicine.
Shan Y; Wang F; Wei Z; Lu Y
Phytomedicine; 2021 Oct; 91():153718. PubMed ID: 34531099
[TBL] [Abstract][Full Text] [Related]
53. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review.
Wei Z; Chen J; Zuo F; Guo J; Sun X; Liu D; Liu C
J Ethnopharmacol; 2023 Jan; 300():115748. PubMed ID: 36162545
[TBL] [Abstract][Full Text] [Related]
54. A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19.
Ruchawapol C; Fu WW; Xu HX
Phytomedicine; 2022 Sep; 104():154324. PubMed ID: 35841663
[TBL] [Abstract][Full Text] [Related]
55. The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis.
Yu G; Guo M; Zou J; Zhou X; Ma Y
Medicine (Baltimore); 2020 Sep; 99(38):e22181. PubMed ID: 32957343
[TBL] [Abstract][Full Text] [Related]
56. Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases.
Xu M; Zhang D; Yan J
Phytomedicine; 2024 Jul; 130():155738. PubMed ID: 38824825
[TBL] [Abstract][Full Text] [Related]
57. Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review.
Jin X; Dong W; Chang K; Yan Y
J Ethnopharmacol; 2024 May; 326():117850. PubMed ID: 38331124
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review.
Zhang X; Jiang Z; Jin X; Zhou Q
Medicine (Baltimore); 2024 Feb; 103(5):e37052. PubMed ID: 38306552
[TBL] [Abstract][Full Text] [Related]
59. Multi-omics and network pharmacology study reveals the effects of Dengzhan Shengmai capsule against neuroinflammatory injury and thrombosis induced by ischemic stroke.
Ye J; Huang F; Zeng H; Xu X; Wu G; Tian S; Zhao J; Zhang W
J Ethnopharmacol; 2023 Apr; 305():116092. PubMed ID: 36587875
[TBL] [Abstract][Full Text] [Related]
60. Examining patterns of traditional Chinese medicine use in pediatric oncology: A systematic review, meta-analysis and data-mining study.
Lam CS; Peng LW; Yang LS; Chou HWJ; Li CK; Zuo Z; Koon HK; Cheung YT
J Integr Med; 2022 Sep; 20(5):402-415. PubMed ID: 35750623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
